FDA Drug recall D1292-2014
METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwa…
- FDA Drug
- Class II
- terminated
- Published 2014-05-21
On 2014-05-21 the FDA classified a Class II recall of METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwa… by Teva Pharmaceuticals Usa, citing CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D1292-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-03-24 |
| Published | 2014-05-21 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-2932-01
Reason
CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
Identifiers
| code_info | TE36053A,TE36063A, Exp. 06/16 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D1292-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.